SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+9.74%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$554M
AUM Growth
+$554M
(-2.4%)
Cap. Flow
-$70.7M
Cap. Flow
% of AUM
-12.76%
Top 10 Holdings %
Top 10 Hldgs %
48.85%
Holding
147
New
23
Increased
32
Reduced
53
Closed
29
Top Buys
| 1 |
Ormat Technologies
ORA
|
$19.9M |
| 2 |
Pfizer
PFE
|
$19.5M |
| 3 |
Biogen
BIIB
|
$11.9M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$5.76M |
| 5 |
Opko Health
OPK
|
$5.03M |
Top Sells
| 1 |
Elbit Systems
ESLT
|
$29.2M |
| 2 |
SHPG
Shire pic
SHPG
|
$26.6M |
| 3 |
AGN
Allergan plc
AGN
|
$24.1M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$12.7M |
| 5 |
Viatris
VTRS
|
$8.05M |
Sector Composition
| 1 | Healthcare | 74.78% |
| 2 | Utilities | 7.14% |
| 3 | Technology | 2.29% |
| 4 | Consumer Discretionary | 1.7% |
| 5 | Communication Services | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $51.5M | 7.54% | 784,850 +31,945 | +4% | +$2.1M |
|
|
2
Ormat Technologies
ORA
$5.56B
| $38.7M | 5.67% | 272,462 +139,803 | +105% | +$19.9M |
|
|
3
Pfizer
PFE
$141B
| $38M | 5.56% | 1,176,612 +602,599 | +105% | +$19.5M |
|
|
4
Biogen
BIIB
$19.4B
| $37.9M | 5.56% | 123,850 +38,850 | +46% | +$11.9M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $31.3M | 4.58% | 100,000 -77,100 | -44% | -$24.1M |
|
6
AbbVie
ABBV
$372B
| $21.4M | 3.14% | 362,000 +35,000 | +11% | +$2.07M |
|
|
CELG
7
DELISTED
Celgene Corp
CELG
| $17.6M | 2.58% | 147,200 +27,200 | +23% | +$3.26M |
|
8
Gilead Sciences
GILD
$140B
| $14.4M | 2.11% | 142,700 +22,700 | +19% | +$2.3M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $11.3M | 1.65% | 59,164 +24,164 | +69% | +$4.61M |
|
10
Bristol-Myers Squibb
BMY
$96B
| $8.36M | 1.22% | 121,500 -28,500 | -19% | -$1.96M |
|
|
SHPG
11
DELISTED
Shire pic
SHPG
| $8.2M | 1.2% | 40,000 -129,751 | -76% | -$26.6M |
|
|
ACOR
12
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $6.12M | 0.9% | 143,000 -127,000 | -47% | -$5.43M |
|
13
Vertex Pharmaceuticals
VRTX
$100B
| $6.09M | 0.89% | 48,400 +8,400 | +21% | +$1.06M |
|
|
FPRX
14
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $6.02M | 0.88% | 145,000 -30,000 | -17% | -$1.25M |
|
|
15
Alphabet (Google) Class C
GOOG
$2.58T
| $5.76M | 0.84% | +7,409 | New | +$5.76M |
|
16
Incyte
INCY
$16.5B
| $5.6M | 0.82% | 51,621 -48,379 | -48% | -$5.25M |
|
|
SAGE
17
DELISTED
Sage Therapeutics
SAGE
| $5.42M | 0.79% | 93,000 +85,000 | +1,063% | +$4.96M |
|
|
CEL
18
DELISTED
Cellcom Israel, Ltd.
CEL
| $5.14M | 0.75% | 212,300 -145,152 | -41% | -$3.52M |
|
19
Ionis Pharmaceuticals
IONS
$6.79B
| $5.03M | 0.74% | 81,200 +13,200 | +19% | +$818K |
|
|
20
Opko Health
OPK
$1.1B
| $5.03M | 0.74% | +500,000 | New | +$5.03M |
|
21
MacroGenics
MGNX
$112M
| $4.74M | 0.69% | 153,000 -17,000 | -10% | -$526K |
|
|
BLCM
22
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $4.69M | 0.69% | 231,515 +1 | +0% | +$20 |
|
23
Check Point Software Technologies
CHKP
$20.7B
| $4.55M | 0.67% | 55,857 -16,470 | -23% | -$1.34M |
|
|
PTLA
24
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.4M | 0.64% | 85,500 -9,500 | -10% | -$489K |
|
|
MRNS
25
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $4.36M | 0.64% | 570,908 +408,788 | +252% | +$3.12M |
|